CancerCure

Monitoring the progress and approval process for a completely new chemical entity (NCE) invented by applied molecular biologist, Dennis Wright. A new class of alpha amino acids is reproducing and extending prior antineoplastic indications. The information provided is not a substitute for professional medical advice, diagnosis or treatment.

15 November 2011

HISTIDINE DERIVATIVES - United States Patent Application Publication

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Contact Info

drwright442000@yahoo.com

Twitter:

@CancerCureNow


Dennis Wright (holding grapes)

Cancer Research and Discussion Links

  • http://gritsforbreakfast.blogspot.com/
  • National Cancer Institute
  • Scientific American
  • The Lancet Oncology
  • The New England Journal of Medicine

Blog Archive

  • ►  2015 (1)
    • ►  March (1)
  • ►  2014 (1)
    • ►  September (1)
  • ►  2013 (3)
    • ►  December (1)
    • ►  April (1)
    • ►  March (1)
  • ►  2012 (5)
    • ►  June (1)
    • ►  March (1)
    • ►  January (3)
  • ▼  2011 (10)
    • ►  December (1)
    • ▼  November (1)
      • HISTIDINE DERIVATIVES - United States Patent Appli...
    • ►  October (2)
    • ►  August (6)

HEP G2 (Liver cancer)
web counter
web counter

Followers

DrWright. Theme images by luoman. Powered by Blogger.